PetMed Express is an online pet pharmacy that delivers prescription and over-the-counter meds for dogs, cats, and horses straight to your door. Think of it as a mail-order drugstore for your furry family members.
The company makes money by selling pet medications and supplies, but it's currently losing money: net income was -USD 0.06B in fiscal 2026, with a net margin of -32%. Revenue is shrinking, down from USD 0.27B in 2024 to USD 0.18B in 2026.
PetMed's brand and customer relationships provide some stickiness, but the moat is eroding as big-box retailers like Chewy and Amazon offer similar products with faster shipping and competitive pricing, pulling customers away.
Key events, in time order
Q1 loss of $0.28 per share misses Zacks consensus estimate of $0.12 loss; revenue declines year over year, though lower costs and stronger recurring sales signal progress
Multiple independent sources confirm the company's earnings release window
None yet
None yet
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
